Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127832471 | 12783247 | 1 | I | 20160915 | 20160927 | 20160927 | EXP | US-MLMSERVICE-20160909-0419425-1 | US-ALKEM LABORATORIES LIMITED-US-ALKEM-2016-00192 | ALKEM | 55.00 | YR | M | Y | 0.00000 | 20160927 | CN | GB | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127832471 | 12783247 | 1 | PS | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | UNKNOWN | 78925 | |||||||||||
| 127832471 | 12783247 | 2 | SS | LABETALOL | LABETALOLLABETALOL HYDROCHLORIDE | 1 | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127832471 | 12783247 | 1 | Product used for unknown indication |
| 127832471 | 12783247 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127832471 | 12783247 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127832471 | 12783247 | Bradycardia | |
| 127832471 | 12783247 | Dysarthria | |
| 127832471 | 12783247 | Hypotension | |
| 127832471 | 12783247 | Intentional overdose | |
| 127832471 | 12783247 | Mental status changes | |
| 127832471 | 12783247 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |